Scientist tests Cancer-Killing virus on himself to watch immune system in action
NCT ID NCT07302945
First seen Jan 08, 2026 · Last updated May 17, 2026 · Updated 18 times
Summary
This study involved one healthy volunteer (the lead researcher) who gave himself a single dose of an experimental oncolytic virus called OTS-412. The goal was not to treat a disease but to closely monitor how the immune system responds over time after receiving the virus. Researchers took frequent blood samples to track changes in immune cells, helping to understand real-time immune dynamics that are hard to capture in cancer patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pusan National University Medical college
Busan, 50612, South Korea
Conditions
Explore the condition pages connected to this study.